Correction: Systematic discovery of drug action mechanisms by an integrated chemical genomics approach: Identification of functional disparities between azacytidine and decitabine [Oncotarget. 7, (2016), 27363-27378] doi 10.18632/oncotarget.8455

Yao Yu Hsieh, Tsui Chin Huang, Hsiang Ling Lo, Jyun Yan Jhan, Shui Tein Chen, Pei Ming Yang

Research output: Contribution to journalComment/debate

Abstract

This article has been corrected: The author affiliation is given below: Yao-Yu Hsieh1,2,5 5 Department of Internal Medicine, Division of Hematology and Oncology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.

Original languageEnglish
Pages (from-to)32402
Number of pages1
JournalOncotarget
Volume9
Issue number64
DOIs
Publication statusPublished - May 10 2016

Fingerprint

decitabine
Azacitidine
Drug Discovery
Genomics
Medicine
Hematology
Internal Medicine
Taiwan

ASJC Scopus subject areas

  • Oncology

Cite this

@article{fe6326bd10ef4836b0d557ca847ee0ed,
title = "Correction: Systematic discovery of drug action mechanisms by an integrated chemical genomics approach: Identification of functional disparities between azacytidine and decitabine [Oncotarget. 7, (2016), 27363-27378] doi 10.18632/oncotarget.8455",
abstract = "This article has been corrected: The author affiliation is given below: Yao-Yu Hsieh1,2,5 5 Department of Internal Medicine, Division of Hematology and Oncology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.",
author = "Hsieh, {Yao Yu} and Huang, {Tsui Chin} and Lo, {Hsiang Ling} and Jhan, {Jyun Yan} and Chen, {Shui Tein} and Yang, {Pei Ming}",
year = "2016",
month = "5",
day = "10",
doi = "10.18632/oncotarget.26019",
language = "English",
volume = "9",
pages = "32402",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals LLC",
number = "64",

}

TY - JOUR

T1 - Correction

T2 - Systematic discovery of drug action mechanisms by an integrated chemical genomics approach: Identification of functional disparities between azacytidine and decitabine [Oncotarget. 7, (2016), 27363-27378] doi 10.18632/oncotarget.8455

AU - Hsieh, Yao Yu

AU - Huang, Tsui Chin

AU - Lo, Hsiang Ling

AU - Jhan, Jyun Yan

AU - Chen, Shui Tein

AU - Yang, Pei Ming

PY - 2016/5/10

Y1 - 2016/5/10

N2 - This article has been corrected: The author affiliation is given below: Yao-Yu Hsieh1,2,5 5 Department of Internal Medicine, Division of Hematology and Oncology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.

AB - This article has been corrected: The author affiliation is given below: Yao-Yu Hsieh1,2,5 5 Department of Internal Medicine, Division of Hematology and Oncology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.

UR - http://www.scopus.com/inward/record.url?scp=85051821483&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85051821483&partnerID=8YFLogxK

U2 - 10.18632/oncotarget.26019

DO - 10.18632/oncotarget.26019

M3 - Comment/debate

AN - SCOPUS:85051821483

VL - 9

SP - 32402

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 64

ER -